The Experts below are selected from a list of 63330 Experts worldwide ranked by ideXlab platform

Brendan J Vote - One of the best experts on this subject based on the ideXlab platform.

  • cost effectiveness of femtosecond laser assisted Cataract Surgery versus phacoemulsification Cataract Surgery
    Ophthalmology, 2014
    Co-Authors: Robin G Abell, Brendan J Vote
    Abstract:

    Purpose To perform a comparative cost-effectiveness analysis (CEA) of femtosecond laser-assisted Cataract Surgery (LCS) and conventional phacoemulsification Cataract Surgery (PCS) Design Retrospective CEA using computer-based econometric modeling. Participants Hypothetical cohort of patients undergoing Cataract Surgery in the better eye based on a review of the current literature and our direct experience using LCS. Methods A cost-effectiveness decision tree model was constructed to analyze the cost-effectiveness of LCS compared with PCS. Complication rates of Cataract Surgery were obtained from a review of the current literature to complete the cohort of patients and outcomes. This data was incorporated with time trade-off utility values converted from visual acuity outcomes. Main Outcome Measures Improvements in best-corrected visual acuity obtained from the literature were used to calculate the increase in quality-adjusted life-years (QALYs) in a hypothetical cohort between 6 months and 1 year after Cataract Surgery. This was combined with approximate costs in a cost–utility analysis model to determine the incremental cost-effectiveness ratios (ICERs). Results Based on the simulated complication rates of PCS and LCS and assuming resultant visual acuity outcome improvement of 5% in uncomplicated cases of LCS, the cost-effectiveness (dollars spent per QALY) gained from LCS was not cost-effective at $92 862 Australian Dollars. The total QALY gain for LCS over PCS was 0.06 units. Multivariate sensitivity analyses revealed that LCS would need to significantly improve visual outcomes and complications rates over PCS, along with a reduction in cost to patient, to improve cost effectiveness. Modeling a best-case scenario of LCS with excellent visual outcomes (100%), a significant reduction in complications (0%) and a significantly reduced cost to patient (of $300) resulted in an ICER of $20 000. Conclusions Laser Cataract Surgery, irrespective of potential improvements in visual acuity outcomes and complication rates, is not cost effective at its current cost to patient when compared with cost-effectiveness benchmarks and other medical interventions, including PCS. A significant reduction in the cost to patient (via reduced consumable/click cost) would increase the likelihood of LCS being considered cost effective.

  • anterior chamber flare after femtosecond laser assisted Cataract Surgery
    Journal of Cataract and Refractive Surgery, 2013
    Co-Authors: Robin G Abell, Penelope L Allen, Brendan J Vote
    Abstract:

    Purpose To determine whether postoperative ocular inflammation is less after femtosecond laser–assisted Cataract Surgery than after conventional phacoemulsification (manual) Cataract Surgery. Setting Private clinic, Launceston, Tasmania, Australia. Design Prospective consecutive investigator-masked nonrandomized parallel cohort study. Methods Consecutive Cataract patients who had femtosecond laser–assisted Cataract Surgery or manual Cataract Surgery by the same surgeon at a single center were assessed. The primary endpoint was postoperative aqueous flare measured by laser flare photometry at 1 day and 4 weeks. Secondary endpoints included retinal thickness measured by optical coherence tomography and slitlamp examination findings at 4 weeks. Results The per-protocol population comprised 176 patients (100 in laser group; 76 in manual group). Postoperative aqueous flare was significantly greater in the manual Cataract Surgery group at 1 day (P=.0089) and at 4 weeks (P=.003). There was a significant correlation between effective phacoemulsification time and 1-day postoperative aqueous flare (r = 0.35, P Conclusion Anterior segment inflammation was less after femtosecond laser–assisted Cataract Surgery than after manual Cataract Surgery, and this appeared to be due to a reduction in phacoemulsification energy. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

  • femtosecond laser assisted Cataract Surgery compared with conventional Cataract Surgery
    Clinical and Experimental Ophthalmology, 2013
    Co-Authors: Robin G Abell, Nathan M Kerr, Brendan J Vote
    Abstract:

    Abstract To investigate the safety and efficacy of the Catalys (Optimedica, Santa Clara, CA, USA) femtosecond laser-assisted Cataract Surgery system compared with conventional phacoemulsification Cataract extraction. Prospective, consecutive, parallel cohort study. The first 200 eyes undergoing conventional Cataract Surgery to the first 200 eyes undergoing femtosecond laser-assisted Cataract Surgery between April and July 2012. Femtosecond laser-assisted Cataract Surgery involved anterior capsulotomy and lens fragmentation based on optical coherence tomography-guided treatment mapping. Conventional Cataract Surgery involved manual continuous curvilinear capsulorhexis. Both procedures were completed by standard phacoemulsification and insertion of an intraocular lens. Effective phacoemulsification time and intraoperative complication rates. Patient demographics were similar between both groups. There was no statistically significant difference in intraoperative complications between femtosecond laser-assisted Cataract Surgery and conventional Surgery. There was one posterior capsule rupture in both groups (0.5%; not significant). One hundred per cent of cases treated with the femtosecond laser had a complete capsulotomy. Vacuum time decreased with experience. Effective phacoemulsification time was reduced by 70% in the femtosecond group (P

Robin G Abell - One of the best experts on this subject based on the ideXlab platform.

  • cost effectiveness of femtosecond laser assisted Cataract Surgery versus phacoemulsification Cataract Surgery
    Ophthalmology, 2014
    Co-Authors: Robin G Abell, Brendan J Vote
    Abstract:

    Purpose To perform a comparative cost-effectiveness analysis (CEA) of femtosecond laser-assisted Cataract Surgery (LCS) and conventional phacoemulsification Cataract Surgery (PCS) Design Retrospective CEA using computer-based econometric modeling. Participants Hypothetical cohort of patients undergoing Cataract Surgery in the better eye based on a review of the current literature and our direct experience using LCS. Methods A cost-effectiveness decision tree model was constructed to analyze the cost-effectiveness of LCS compared with PCS. Complication rates of Cataract Surgery were obtained from a review of the current literature to complete the cohort of patients and outcomes. This data was incorporated with time trade-off utility values converted from visual acuity outcomes. Main Outcome Measures Improvements in best-corrected visual acuity obtained from the literature were used to calculate the increase in quality-adjusted life-years (QALYs) in a hypothetical cohort between 6 months and 1 year after Cataract Surgery. This was combined with approximate costs in a cost–utility analysis model to determine the incremental cost-effectiveness ratios (ICERs). Results Based on the simulated complication rates of PCS and LCS and assuming resultant visual acuity outcome improvement of 5% in uncomplicated cases of LCS, the cost-effectiveness (dollars spent per QALY) gained from LCS was not cost-effective at $92 862 Australian Dollars. The total QALY gain for LCS over PCS was 0.06 units. Multivariate sensitivity analyses revealed that LCS would need to significantly improve visual outcomes and complications rates over PCS, along with a reduction in cost to patient, to improve cost effectiveness. Modeling a best-case scenario of LCS with excellent visual outcomes (100%), a significant reduction in complications (0%) and a significantly reduced cost to patient (of $300) resulted in an ICER of $20 000. Conclusions Laser Cataract Surgery, irrespective of potential improvements in visual acuity outcomes and complication rates, is not cost effective at its current cost to patient when compared with cost-effectiveness benchmarks and other medical interventions, including PCS. A significant reduction in the cost to patient (via reduced consumable/click cost) would increase the likelihood of LCS being considered cost effective.

  • anterior chamber flare after femtosecond laser assisted Cataract Surgery
    Journal of Cataract and Refractive Surgery, 2013
    Co-Authors: Robin G Abell, Penelope L Allen, Brendan J Vote
    Abstract:

    Purpose To determine whether postoperative ocular inflammation is less after femtosecond laser–assisted Cataract Surgery than after conventional phacoemulsification (manual) Cataract Surgery. Setting Private clinic, Launceston, Tasmania, Australia. Design Prospective consecutive investigator-masked nonrandomized parallel cohort study. Methods Consecutive Cataract patients who had femtosecond laser–assisted Cataract Surgery or manual Cataract Surgery by the same surgeon at a single center were assessed. The primary endpoint was postoperative aqueous flare measured by laser flare photometry at 1 day and 4 weeks. Secondary endpoints included retinal thickness measured by optical coherence tomography and slitlamp examination findings at 4 weeks. Results The per-protocol population comprised 176 patients (100 in laser group; 76 in manual group). Postoperative aqueous flare was significantly greater in the manual Cataract Surgery group at 1 day (P=.0089) and at 4 weeks (P=.003). There was a significant correlation between effective phacoemulsification time and 1-day postoperative aqueous flare (r = 0.35, P Conclusion Anterior segment inflammation was less after femtosecond laser–assisted Cataract Surgery than after manual Cataract Surgery, and this appeared to be due to a reduction in phacoemulsification energy. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.

  • femtosecond laser assisted Cataract Surgery compared with conventional Cataract Surgery
    Clinical and Experimental Ophthalmology, 2013
    Co-Authors: Robin G Abell, Nathan M Kerr, Brendan J Vote
    Abstract:

    Abstract To investigate the safety and efficacy of the Catalys (Optimedica, Santa Clara, CA, USA) femtosecond laser-assisted Cataract Surgery system compared with conventional phacoemulsification Cataract extraction. Prospective, consecutive, parallel cohort study. The first 200 eyes undergoing conventional Cataract Surgery to the first 200 eyes undergoing femtosecond laser-assisted Cataract Surgery between April and July 2012. Femtosecond laser-assisted Cataract Surgery involved anterior capsulotomy and lens fragmentation based on optical coherence tomography-guided treatment mapping. Conventional Cataract Surgery involved manual continuous curvilinear capsulorhexis. Both procedures were completed by standard phacoemulsification and insertion of an intraocular lens. Effective phacoemulsification time and intraoperative complication rates. Patient demographics were similar between both groups. There was no statistically significant difference in intraoperative complications between femtosecond laser-assisted Cataract Surgery and conventional Surgery. There was one posterior capsule rupture in both groups (0.5%; not significant). One hundred per cent of cases treated with the femtosecond laser had a complete capsulotomy. Vacuum time decreased with experience. Effective phacoemulsification time was reduced by 70% in the femtosecond group (P

Jennifer R Evans - One of the best experts on this subject based on the ideXlab platform.

  • laser assisted Cataract Surgery versus standard ultrasound phacoemulsification Cataract Surgery
    Cochrane Database of Systematic Reviews, 2016
    Co-Authors: Daniel M Gore, Catey Bunce, Jennifer R Evans
    Abstract:

    BACKGROUND: Cataract is the leading cause of blindness in the world, and Cataract Surgery is one of the most commonly performed operations in the Western world. Preferred surgical techniques have changed dramatically over the past half century with associated improvements in outcomes and safety. Femtosecond laser platforms that can accurately and reproducibly perform key steps in Cataract Surgery, including corneal incisions, capsulotomy and lens fragmentation, are now available. The potential advantages of laser-assisted Surgery are broad, and include greater safety and better visual outcomes through greater precision and reproducibility. OBJECTIVES: To compare the effectiveness of laser-assisted Cataract Surgery with standard ultrasound phacoemulsification Cataract Surgery by gathering evidence on safety from randomised controlled trials (RCTs). SEARCH METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 4), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to May 2016), EMBASE (January 1980 to May 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to May 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en) and the U.S. Food and Drugs Administration (FDA) website (www.fda.gov). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 10 May 2016. SELECTION CRITERIA: We included randomised controlled trials where laser-assisted Cataract Surgery was compared to standard ultrasound phacoemulsification Cataract Surgery. We graded the certainty of the evidence using GRADE. DATA COLLECTION AND ANALYSIS: Two review authors independently screened the search results, assessed risk of bias and extracted data using the standard methodological procedures expected by Cochrane. The primary outcome for this review was intraoperative complications in the operated eye, namely anterior capsule and posterior capsule tears. The secondary outcomes were visual acuity (corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA)), refractive outcomes, quality of vision (as measured by any validated visual function score), postoperative complications and cost-effectiveness. MAIN RESULTS: We included 16 RCTs conducted in Germary, Hungary, Italy, India, China and Brazil that enrolled a total of 1638 eyes of 1245 adult participants. Overall, the studies were at unclear or high risk of bias. In 11 of the studies the authors reported financial links with the manufacturer of the laser platform evaluated in their studies. Five of the studies were within-person (paired-eye) studies with one eye allocated to one procedure and the other eye allocated to the other procedure. These studies were reported ignoring the paired nature of the data.The number of anterior capsule and posterior capsule tears reported in the included studies for both laser Cataract Surgery and manual phacoemulsification Cataract Surgery were low. There were four anterior capsule tears and one posterior capsule tear in 1076 eyes reported in 10 studies (2 anterior capsule tears in laser arms, 2 anterior capsule tears and 1 posterior capsule tear in standard phacoemulsification arms). We are very uncertain as to the effect of laser-assisted Surgery compared to standard phacoemulsification Surgery with respect to these two outcomes. For postoperative cystoid macular oedema and elevated postoperative intraocular pressures, again the evidence was inconclusive (odds ratio (OR) 0.58, 95% confidence interval (CI) 0.20 to 1.68; 957 eyes, 9 studies, low certainty evidence; and OR 0.57, 95% CI 0.11 to 2.86; 903 eyes, 8 studies, low certainty evidence).We found little evidence of any important difference in postoperative visual acuity between laser-assisted and standard phacoemulsification arms. There was a small advantage for laser-assisted Cataract Surgery at six months in CDVA. However, the mean difference (MD) was -0.03 logMAR (95% CI -0.05 to -0.00; 224 eyes, 3 studies, low certainty evidence) which is equivalent to 1.5 logMAR letters and is therefore, clinically insignificant. No studies reported patient-reported outcome measures such as visual function.There were no data reported on costs or resource use but three studies reported the time taken to do the Surgery. There was little evidence of any major difference between the two procedures in this respect (MD 0.1 minutes, 95% CI -0.02 to 0.21; 274 eyes, low certainty evidence). AUTHORS' CONCLUSIONS: The evidence from the 16 randomised controlled trials RCTs included in this review could not determine the equivalence or superiority of laser-assisted Cataract Surgery compared to standard manual phacoemulsification for our chosen outcomes due to the low to very low certainty of the evidence available from these studies. As complications occur rarely, large, adequately powered, well designed, independent RCTs comparing the safety and efficacy of laser-assisted Cataract Surgery with standard phacoemulsification Cataract Surgery are needed. Standardised reporting of complications and visual and refractive outcomes for Cataract Surgery would facilitate future synthesis. Data on patient-reported outcomes and cost-effectiveness are needed. Paired-eye studies should be analysed and reported appropriately.

Nathan M Kerr - One of the best experts on this subject based on the ideXlab platform.

  • femtosecond laser assisted Cataract Surgery compared with conventional Cataract Surgery
    Clinical and Experimental Ophthalmology, 2013
    Co-Authors: Robin G Abell, Nathan M Kerr, Brendan J Vote
    Abstract:

    Abstract To investigate the safety and efficacy of the Catalys (Optimedica, Santa Clara, CA, USA) femtosecond laser-assisted Cataract Surgery system compared with conventional phacoemulsification Cataract extraction. Prospective, consecutive, parallel cohort study. The first 200 eyes undergoing conventional Cataract Surgery to the first 200 eyes undergoing femtosecond laser-assisted Cataract Surgery between April and July 2012. Femtosecond laser-assisted Cataract Surgery involved anterior capsulotomy and lens fragmentation based on optical coherence tomography-guided treatment mapping. Conventional Cataract Surgery involved manual continuous curvilinear capsulorhexis. Both procedures were completed by standard phacoemulsification and insertion of an intraocular lens. Effective phacoemulsification time and intraoperative complication rates. Patient demographics were similar between both groups. There was no statistically significant difference in intraoperative complications between femtosecond laser-assisted Cataract Surgery and conventional Surgery. There was one posterior capsule rupture in both groups (0.5%; not significant). One hundred per cent of cases treated with the femtosecond laser had a complete capsulotomy. Vacuum time decreased with experience. Effective phacoemulsification time was reduced by 70% in the femtosecond group (P

Daniel M Gore - One of the best experts on this subject based on the ideXlab platform.

  • laser assisted Cataract Surgery versus standard ultrasound phacoemulsification Cataract Surgery
    Cochrane Database of Systematic Reviews, 2016
    Co-Authors: Daniel M Gore, Catey Bunce, Jennifer R Evans
    Abstract:

    BACKGROUND: Cataract is the leading cause of blindness in the world, and Cataract Surgery is one of the most commonly performed operations in the Western world. Preferred surgical techniques have changed dramatically over the past half century with associated improvements in outcomes and safety. Femtosecond laser platforms that can accurately and reproducibly perform key steps in Cataract Surgery, including corneal incisions, capsulotomy and lens fragmentation, are now available. The potential advantages of laser-assisted Surgery are broad, and include greater safety and better visual outcomes through greater precision and reproducibility. OBJECTIVES: To compare the effectiveness of laser-assisted Cataract Surgery with standard ultrasound phacoemulsification Cataract Surgery by gathering evidence on safety from randomised controlled trials (RCTs). SEARCH METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 4), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to May 2016), EMBASE (January 1980 to May 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to May 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en) and the U.S. Food and Drugs Administration (FDA) website (www.fda.gov). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 10 May 2016. SELECTION CRITERIA: We included randomised controlled trials where laser-assisted Cataract Surgery was compared to standard ultrasound phacoemulsification Cataract Surgery. We graded the certainty of the evidence using GRADE. DATA COLLECTION AND ANALYSIS: Two review authors independently screened the search results, assessed risk of bias and extracted data using the standard methodological procedures expected by Cochrane. The primary outcome for this review was intraoperative complications in the operated eye, namely anterior capsule and posterior capsule tears. The secondary outcomes were visual acuity (corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA)), refractive outcomes, quality of vision (as measured by any validated visual function score), postoperative complications and cost-effectiveness. MAIN RESULTS: We included 16 RCTs conducted in Germary, Hungary, Italy, India, China and Brazil that enrolled a total of 1638 eyes of 1245 adult participants. Overall, the studies were at unclear or high risk of bias. In 11 of the studies the authors reported financial links with the manufacturer of the laser platform evaluated in their studies. Five of the studies were within-person (paired-eye) studies with one eye allocated to one procedure and the other eye allocated to the other procedure. These studies were reported ignoring the paired nature of the data.The number of anterior capsule and posterior capsule tears reported in the included studies for both laser Cataract Surgery and manual phacoemulsification Cataract Surgery were low. There were four anterior capsule tears and one posterior capsule tear in 1076 eyes reported in 10 studies (2 anterior capsule tears in laser arms, 2 anterior capsule tears and 1 posterior capsule tear in standard phacoemulsification arms). We are very uncertain as to the effect of laser-assisted Surgery compared to standard phacoemulsification Surgery with respect to these two outcomes. For postoperative cystoid macular oedema and elevated postoperative intraocular pressures, again the evidence was inconclusive (odds ratio (OR) 0.58, 95% confidence interval (CI) 0.20 to 1.68; 957 eyes, 9 studies, low certainty evidence; and OR 0.57, 95% CI 0.11 to 2.86; 903 eyes, 8 studies, low certainty evidence).We found little evidence of any important difference in postoperative visual acuity between laser-assisted and standard phacoemulsification arms. There was a small advantage for laser-assisted Cataract Surgery at six months in CDVA. However, the mean difference (MD) was -0.03 logMAR (95% CI -0.05 to -0.00; 224 eyes, 3 studies, low certainty evidence) which is equivalent to 1.5 logMAR letters and is therefore, clinically insignificant. No studies reported patient-reported outcome measures such as visual function.There were no data reported on costs or resource use but three studies reported the time taken to do the Surgery. There was little evidence of any major difference between the two procedures in this respect (MD 0.1 minutes, 95% CI -0.02 to 0.21; 274 eyes, low certainty evidence). AUTHORS' CONCLUSIONS: The evidence from the 16 randomised controlled trials RCTs included in this review could not determine the equivalence or superiority of laser-assisted Cataract Surgery compared to standard manual phacoemulsification for our chosen outcomes due to the low to very low certainty of the evidence available from these studies. As complications occur rarely, large, adequately powered, well designed, independent RCTs comparing the safety and efficacy of laser-assisted Cataract Surgery with standard phacoemulsification Cataract Surgery are needed. Standardised reporting of complications and visual and refractive outcomes for Cataract Surgery would facilitate future synthesis. Data on patient-reported outcomes and cost-effectiveness are needed. Paired-eye studies should be analysed and reported appropriately.